News Releaseのカテゴリー News
-
IAM is announcing a collaboration with the Institute of Physical and Chemical Research (RIKEN) covering multiple therapeutic areas.
-
IAM’s CEO, Hiroyuki Kouji, will be presenting a lecture at the 25th meeting of The Japanese Association for Molecular Target Therapy of Cancer (May 26-28)
-
Hiroyuki Kouji appointed as new CEO
-
IAM wins Grand Prize in “16th Oita Business Plan Grand Prix”
-
“Drug Development Cluster Plan” introduced in Oita Godo Shimbun
-
IAM as first venture company to be supported by Kyusyu Venture Promotion Committee